UK-based Scindo Raises €4.5 Million Funding

The round was co-led by Kadmos Capital and Clay Capital, with participation from PINC (Paulig’s venture arm) and existing investors Synbioven, AgFunder, SOSV, Farvatn Venture, and Savantus Ventures.

"We’re thrilled to have the backing of such a strong consortium of investors," said Gustaf Hemberg, Co-founder & CEO of Scindo. "This support enables us to accelerate the scale-up of our enzyme platform and start producing sustainable, high-value products that will help transform how industries approach ingredient sourcing and production."

Scindo, founded in 2020, is a biotech startup revolutionizing enzyme discovery through AI to create sustainable alternatives to petroleum-based chemicals. Its proprietary, data-driven platform integrates experimental reaction data with advanced AI to discover, design, and optimize enzymes that break down complex feedstocks into bioactive ingredients.

Read Also - Goodvest Secures €12M Funding In Series B Round

Scindo’s full-stack system engineers natural catalytic proteins to convert renewable feedstocks into high-value, bio-based ingredients, enabling scalable and consistent production for food, flavors, cosmetics and specialty chemicals.

"Scindo represents exactly the type of company we seek to back – one that combines data-driven approaches with strong technical talent to address sustainability challenges," said Remy Kesrouani, Managing Partner at Kadmos Capital. "Their use of validated experimental data to inform enzyme engineering backed by exceptional UK academic expertise, aligns well with our investment thesis. "

The company’s technology is attracting strong industry interest with partnerships already in place with leading specialty chemical makers and pilot programs preparing its first products for market. This highlights the rising demand for bio based solutions that deliver both high performance and sustainable production at scale.

The new funding will enable Scindo to expand its enzyme discovery platform, scale its wet-lab operations, and grow its team. Recent hires include research scientists from leading pharma firms and the University of Oxford, enhancing capabilities in machine learning, enzyme engineering, process scale-up and commercialization.

"The specialty chemicals industry has long sought to move away from petrochemical-derived ingredients, but existing approaches have struggled with complex natural feedstocks," said Ali Morrow, Partner at Clay Capital. "Scindo’s approach creates molecular craftsmen – enzymes designed for specific industrial jobs that offer cost-competitive natural alternatives and unlock previously inaccessible feedstocks, creating significant opportunities globally to end the industry’s reliance on crude oil."

About Scindo

Scindo utilizes AI-driven enzyme design to transform industrial chemistry, creating sustainable biocatalysts that reduce energy consumption, waste and reliance on fossil feedstocks. Its enzymes convert renewable or upcycled feedstocks into bioactive ingredients for everyday products, including cosmetics, personal care, nutrients and food, enabling greener, more efficient manufacturing.